When moving from the general population to patients with steatosis, an Asiatic study on 546 patients with fatty liver found that the PNPLA3 G allele progressively increased the risk of developing extrahepatic cancer even if this association was lost after adjusting for the severity of liver fibrosis [89]. The gene discussed is PNPLA3; the disease is fatty liver disease.